← 返回

在结直肠癌中通过基因共表达网络识别与 TIL(肿瘤浸润淋巴细胞)(TILs)浸润相关的生物标志物

英文原题:Identification of biomarkers related to Tumor-Infiltrating Lymphocytes (TILs) infiltration with gene co-expression network in colorectal cancer.

查看英文原题

Identification of biomarkers related to Tumor-Infiltrating Lymphocytes (TILs) infiltration with gene co-expression network in colorectal cancer.

PubMed 2021/12/01(内容时间) Bioengineered

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

结直肠癌(CRC)是最常见的肿瘤之一,在全球癌症死因中排名第二。晚期患者的预后仍然很差。本研究基于基因表达综合数据库中的CRC表达数据,通过加权基因共表达网络分析,识别出与肿瘤浸润免疫细胞关联最强的核心模块。随后,通过共表达网络和预后分析,识别出三个与浸润免疫细胞相关的核心基因(ADAM8、IL-1A、VAV3)。经过TIMER数据库的分析和验证,选择ADAM8作为预后生物标志物。最后,功能试验结果表明,ADAM8基因表达下调部分逆转了CRC细胞对TIL的免疫耐受。通过生物信息学分析方法和实验技术,我们确定了ADAM8作为CRC中与肿瘤浸润免疫细胞相关的预后生物标志物和临床治疗靶点。

展开英文摘要原文

Colorectal cancer (CRC) is one of the most common tumors, ranking second in the global cause of death from cancer. The prognosis of advanced patients is still very poor. In this study, hub modules with the highest association with tumor-infiltrating immune cells were identified by weighted gene co-expression network analysis based on CRC expression data from the Gene Expression Omnibus database.

Next, three hub genes (ADAM8, IL-1A, VAV3) related to infiltrating immune cells were identified by co-expression network and prognostic analysis. After analysis and verification of the TIMER database, ADAM8 was selected as a prognostic biomarker.

Finally, the result of functional test showed that ADAM8 gene expression down-regulation partially reversed the immune tolerance of CRC cells to TILs. By bioinformatics analysis methods and the experimental techniques, we identified ADAM8 as a prognostic biomarker and clinical therapeutic target related to tumor-infiltrating immune cells in CRC.

论文信息

作者
Liao R、Ma QZ、Zhou CY、Li JJ、Weng NN、Yang Y、Zhu Q
单位
Department of Abdominal Oncology, West China Hospital of Sichuan University, Chengdu, Sichuan, P.R. China.China
文献类型
非美国政府资助研究
期刊
Bioengineered2021 Dec
原文标识
PubMed 33960283 · DOI 10.1080/21655979.2021.1921551